Lanean...
The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis
The introduction of interferon beta therapies more than 20 years ago marked a milestone in the treatment of relapsing‐remitting multiple sclerosis (RRMS) with a significant impact on the approach to modern multiple sclerosis (MS) care. Key learnings and perspectives from the early days of disease mo...
Gorde:
| Argitaratua izan da: | Brain Behav |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5474703/ https://ncbi.nlm.nih.gov/pubmed/28638705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.696 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|